Skip to main content
OpenTrials
Completed

NCT Number: NCT03391206

Bioelectrical Impedance Utilization and Dietary Intake Relation in the Breast Cancer Related Lymphedema

The purpose of this study was to investigate the clinical role of bioelectrical impedance analysis (BIA) and the relationship between the occurrence of breast cancer related lymphedema (BCRL) and dietary factors in breast cancer survivors who underwent surgical treatments.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Yonsei University College of Medicine

Seoul, 120-752, South Korea

About this study

Breast cancer survivors are at risk of complications of breast cancer-related lymphedema (BCRL) after surgical treatments, which may negatively effect on the quality of life of breast cancer survivors. Lymphedema has been clinically diagnosed by determining that a limb is in fact swollen, and has arbitrarily been diagnosed in other etiologies. Limb circumference differences of 2 cm, a 200 mL or more in limb, or a 5% volume change are some of the objective ways that clinicians use to diagnose lymphedema. Although the arm circumference measurement method is a simple and frequently used clinical method, there is a disadvantage that the standardized reference point does not exist, the extracellular space can not be measured, and the sensitivity is also low. The lack of evidence-based diagnostic criteria to define lymphedema has presented tremendous difficulty in diagnosing lymphedema. It is important to define such criteria for early detection and treatment of lymphedema. Because of these limitations, many researchers are studying various methods for diagnosing lymphadenopathy and methods of bioelectrical impedance have been studied, recently.

Bioelectrical Impedance predicts body composition using the difference of electric conductivity by flowing a minute current to human body.This principle is used to diagnose the occurrence of lymphatic edema. In several studies, the single-frequency bioimpedance analysis (SFBIA) of the two arms obtained from bioelectrical impedance measurements was expressed as the ratio of the values of the operated and non-operated arms. However, it has not yet been clarified as a diagnostic method. Therefore, more studies are needed to establish a diagnosis method and a prediction method of lymphatic edema.

Various risk factors of lymphedema such as axillary lymph node dissection (ALND) and obesity have been studied for early prevention. However, there are no studies on the relationship between breast cancer related lymphedema, and dietary factors in breast cancer patients. The purpose of this study was to compare the diagnosis of lymphedema with the measurement of the arm circumference and the diagnosis of lymphedema through bioelectrical impedance values in order to clarify the clinical role of bioelectrical impedance method as a diagnostic method of lymphedema. To investigate the relationship between dietary factors, which are considered to be related to the occurrence of lymphedema, the investigators examined the frequency of dietary intake and analyzed the relationship between dietary factors and lymphatic edema.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Breast cancer patients
  • 20 years of age or older who survive after surgery and follow-up

Exclusion criteria

  • Patients with bilateral breast cancer
  • Male breast cancer patient
  • Patients with a history of previous axillary surgery or radiation
  • Recurrent breast cancer subjects
  • Those who can not read or understand the written consent of an illiterate or foreigner
  • Subjects who did not voluntarily decide to participate in this study or who did not sign a consent form
  • The subjects who were judged inappropriate by the researcher to participate in this study

Treatment and study plan

Inbody 720

Diagnostic Test

We investigated the diagnostic accuracy of breast cancer related lymphedema diagnosed by bioimpedance analysis (Inbody 720) and arm circumference measurement..

Other names: bioelectrical impedance analysis

Primary outcomes

  1. Brest cancer related lymphedema

    Time frame: At least six months after the surgical treatment

    Assessed by measuring the circumference at 15.0 centimeter below the acromion process in both arm and circumference difference of greater than or equal to 2.0 centimeter.

Secondary outcomes

  1. BIA

    Time frame: At least six months after the surgical treatment

    bioelectrical impedance values

  2. SFBIA ratio

    Time frame: At least six months after the surgical treatment

    single frequency bioelectrical impedance analysis

  3. BMI

    Time frame: At least six months after the surgical treatment

    body mass index; weight in kilograms(kg) and height in meter(m) will be combined to report BMI in kg/m^2

  4. WHR

    Time frame: At least six months after the surgical treatment

    waist-hip ratio; waist circumference in centimeter(cm) and hip circumference in centimeter(cm) will be combined to report WHR in cm/cm

  5. Percent body fat

    Time frame: At least six months after the surgical treatment

    body fat mass in kilograms(kg) and weight in kilograms(kg) will be combined to report Percent body fat in kg/kg*100 (%)

  6. Nutrient intake analysis

    Time frame: At least six months after the surgical treatment

    nutrient intake was analyzed by a nutrition analysis program (Can-Pro 5.0) through food frequency questionnaire

Sponsors and collaborators

Lead sponsor

Severance Hospital

Other

Registry information

Official study title

Relationship Between Bioelectrical Impedance Utilization and Dietary Intake in the Analysis of Risk of Lymphedema in Breast Cancer Survivors: A Prospective Cross Sectional Study

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jan 5, 2018
Registry last updated
Jan 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.